Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Large B-Cell, Diffuse × R-CHOP protocol × Clear all

Phase

Phase 2 11 Phase 1/2 5 Phase 3 4 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vomiting 1 Nausea 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1

Interventions

Cyclophosphamide 17 fludarabine phosphate 12 Rituximab 12 Peripheral Blood Stem Cell Transplantation 12 Filgrastim 11 Cyclosporine 11 Whole-Body Irradiation 8 Radiotherapy 8 Mycophenolic Acid 8 Busulfan 7 Antilymphocyte Serum 7 Vincristine 6 Prednisone 6 Melphalan 6 Etoposide 6 Methotrexate 5 Psychiatric Rehabilitation 4 Methylprednisolone 4 Cord Blood Stem Cell Transplantation 4 Therapeutics 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Cytarabine 3 Carmustine 3 Aprepitant 3 Analgesia 3 plerixafor 2 Vindesine 2 Tacrolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00530179 2019-01-22

PET-Chop

AHS Cancer Control Alberta

Phase NA Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡